Advances in personalized medicine for lung cancer: What's in it for the patient

Birgitta Hiddinga

doi:10.33612/diss.1004972626

Advances in personalized medicine for lung cancer: What's in it for the patient

Birgitta Hiddinga

Onderzoeksoutput

206 Downloads (Pure)

Samenvatting

This thesis is a plea for finding and using biomarkers, to enhance precision medicine in the treatment of lung cancer patients, and a plea for speeding up the process towards precision medicine (or targeted therapy), because of the obvious benefits that will bring for patients and physicians, such asreducing ineffective therapies and medication.

Originele taal-2	English
Kwalificatie	Doctor of Philosophy
Toekennende instantie	Rijksuniversiteit Groningen
Begeleider(s)/adviseur	Slebos, Dirk Jan, Supervisor van Meerbeeck, Jan P., Supervisor, Externe Persoon
Datum van toekenning	15-mei-2024
Plaats van publicatie	[Groningen]
Uitgever	University of Groningen
DOI's	https://doi.org/10.33612/diss.1004972626
Status	Published - 2024

Toegang tot document

10.33612/diss.1004972626

Title and contentsFinal publisher's version, 1,76 MB
Chapter 1Final publisher's version, 4 MB
Chapter 2Final publisher's version, 1,83 MB
Chapter 3Final publisher's version, 1,69 MB
Chapter 4Final publisher's version, 1,85 MB
Chapter 5Final publisher's version, 2,7 MB
Chapter 6Final publisher's version, 7 MB
Chapter 8Final publisher's version, 4,04 MB
Chapter 9Final publisher's version, 2,59 MB
Chapter 10Final publisher's version, 1,81 MB
Hoofdstuk 11Final publisher's version, 1,8 MB
AppendicesFinal publisher's version, 1,78 MB
PropositionsFinal publisher's version, 1,51 MB

Handle.net

Permanente koppeling

Document onder embargo

Addendum
Final publisher's version, 1,76 MB
Embargo eindigt: 15/05/2025
Kopie aanvragen

Document onder embargo

Chapter 7
Final publisher's version, 12,9 MB
Embargo eindigt: 15/05/2025
Kopie aanvragen

Document onder embargo

Complete thesis
Final publisher's version, 26,1 MB
Embargo eindigt: 15/05/2025
Kopie aanvragen

Citeer dit

@phdthesis{3fb461a6dce14ff7a40e245b9da4a938,

title = "Advances in personalized medicine for lung cancer: What's in it for the patient",

abstract = "This thesis is a plea for finding and using biomarkers, to enhance precision medicine in the treatment of lung cancer patients, and a plea for speeding up the process towards precision medicine (or targeted therapy), because of the obvious benefits that will bring for patients and physicians, such asreducing ineffective therapies and medication.",

author = "Birgitta Hiddinga",

year = "2024",

doi = "10.33612/diss.1004972626",

language = "English",

publisher = "University of Groningen",

school = "University of Groningen",

}

TY - BOOK

T1 - Advances in personalized medicine for lung cancer

T2 - What's in it for the patient

AU - Hiddinga, Birgitta

PY - 2024

Y1 - 2024

N2 - This thesis is a plea for finding and using biomarkers, to enhance precision medicine in the treatment of lung cancer patients, and a plea for speeding up the process towards precision medicine (or targeted therapy), because of the obvious benefits that will bring for patients and physicians, such asreducing ineffective therapies and medication.

AB - This thesis is a plea for finding and using biomarkers, to enhance precision medicine in the treatment of lung cancer patients, and a plea for speeding up the process towards precision medicine (or targeted therapy), because of the obvious benefits that will bring for patients and physicians, such asreducing ineffective therapies and medication.

U2 - 10.33612/diss.1004972626

DO - 10.33612/diss.1004972626

M3 - Thesis fully internal (DIV)

PB - University of Groningen

CY - [Groningen]

ER -

Advances in personalized medicine for lung cancer: What's in it for the patient

Samenvatting

Toegang tot document

Handle.net

Document onder embargo

Document onder embargo

Document onder embargo

Vingerafdruk

Citeer dit